The routine prescription lacks the evidence base many believed it had
For decades, the prescription was simple: calcium, vitamin D, and the bones would hold. But a sweeping review of nearly 154,000 adults, published in The BMJ, quietly dismantles that certainty — finding that supplements long woven into clinical routine offer little meaningful protection against the fractures and falls that reshape so many lives in old age. The evidence does not collapse a concern; it redirects it, pointing toward movement, balance, and the harder work of prevention that cannot be bottled.
- A major Canadian review of 69 randomized trials finds calcium and vitamin D supplements — taken alone or together — do not meaningfully reduce fractures or falls in older adults, contradicting decades of widespread clinical guidance.
- The stakes are high: nearly one in three people over 65 falls each year, and the resulting fractures — especially hip breaks — often trigger pain, loss of independence, and permanent moves into residential care.
- Researchers set rigorous, patient-meaningful thresholds before analyzing data, and the null finding held firm across age, sex, fracture history, and dietary calcium intake, lending the conclusions unusual credibility.
- The gap between what guidelines recommend and what evidence supports is now stark, with researchers calling on clinicians, guideline bodies, and regulators to formally reconsider routine supplementation.
- The path forward points away from the pill bottle and toward balance training, resistance exercise, and personalized fall-prevention programs — interventions with demonstrated benefit but far greater demands on patients and systems alike.
Nearly a third of people over 65 fall each year, and the fractures that follow — broken hips, wrists, spines — often mark a turning point: more pain, a narrower world, sometimes a permanent move into care. For decades, the medical answer has been calcium, vitamin D, or both. Take them. Prevent the break.
A major review published this week in The BMJ challenges that logic directly. Canadian researchers analyzed 69 randomized controlled trials involving nearly 154,000 adults, asking whether these supplements actually reduced fractures and falls compared to placebo or no treatment. Across high-certainty evidence — 11 trials for calcium alone, 36 for vitamin D, 15 for combined supplementation — the answer was largely no. Hip fractures, the breaks most likely to trigger a cascade into residential care, showed no meaningful reduction either.
What makes the findings difficult to dismiss is their consistency. The researchers set clinically meaningful thresholds before analyzing the data, seeking outcomes that would matter to patients rather than statistical traces. When they tested results across subgroups — different ages, sexes, fracture histories, dietary calcium levels — the conclusions held. The evidence did not soften under scrutiny.
The researchers are candid about limits: some analyses rested on few studies, and the findings may not apply to people with specific bone disorders or those already on osteoporosis medications. But the broader implication is clear: clinicians and guideline bodies should reconsider routine supplementation recommendations that have outpaced their evidence base.
The accompanying editorial points toward what should come next — not more supplement trials, but a genuine shift toward interventions that work: balance training, resistance exercise, programs combining physical activity with hazard assessment and personalized education. These approaches require more than swallowing a pill. But for the millions of older adults who have been doing exactly that in hopes of avoiding a fracture, the review carries an unsettling message — the pills may never have been doing what anyone promised.
Nearly a third of people over 65 fall each year. Many of those falls break bones. The fractures that follow—hip breaks, wrist fractures, spinal collapses—reshape lives. They bring pain, they narrow the world, they often mean moving into a care facility. For decades, the medical response has been straightforward: take calcium. Take vitamin D. Take both. Prevent the break before it happens.
But a major review published in The BMJ this week suggests that strategy doesn't work the way we thought it did. Researchers in Canada analyzed 69 randomized controlled trials involving nearly 154,000 adults. They looked at whether calcium supplements alone, vitamin D supplements alone, or the two together actually reduced fractures and falls compared to placebo or no treatment at all. The answer, across high-certainty evidence, was largely no.
The findings challenge a medical consensus that has only grown stronger in recent years. Despite earlier reviews showing inconsistent or absent benefits, clinicians, hospital guidelines, and regulatory agencies have continued recommending vitamin D with or without calcium for bone health. Prescriptions have climbed. The supplements have become routine—something doctors suggest, something people take without much question.
The Canadian team set clinically meaningful thresholds before analyzing the data, a methodological choice that matters. They weren't looking for statistical whispers. They wanted to know if these supplements actually changed outcomes in ways that mattered to patients. For calcium alone, the evidence came from 11 trials covering 9,067 people. For vitamin D, 36 trials and 92,045 participants. For combined supplementation, 15 trials and 51,126 people. Across all three categories, the supplements showed little to no meaningful effect on fracture risk. The same held for falls. Hip fractures specifically—the breaks that most often trigger the cascade into residential care—showed no meaningful reduction either.
The researchers were careful about their caveats. Some analyses drew from a small number of studies. The findings might not apply to people with specific bone disorders or those already taking osteoporosis medications. But when they tested their conclusions against variations in age, sex, prior fracture history, and dietary calcium intake, the results held steady. The strength of the evidence didn't crumble under scrutiny.
What emerges from this review is a gap between what the medical establishment recommends and what the evidence actually supports. The researchers are direct about the implication: clinicians, guideline committees, and regulatory bodies should reconsider their general recommendations for calcium and vitamin D supplementation. The routine prescription, the assumption that these pills prevent breaks, lacks the evidence base many believed it had.
The editorial accompanying the review points toward what should happen next. Rather than waiting for more supplement trials—which may never come—resources should shift toward interventions that do prevent falls and fall injuries: balance training, resistance exercise, programs that combine exercise with hazard assessment and personalized education. These approaches have shown meaningful benefit. They require more effort than swallowing a pill, but they work. For the millions of older adults taking supplements in hopes of avoiding a fracture, the message is unsettling: the pills may not be doing what anyone promised.
Notable Quotes
These findings do not support routine supplementation with calcium or vitamin D, or combined supplementation to prevent fractures and falls— Canadian researchers in The BMJ review
Focus and funding should be redirected towards interventions that have been shown to offer meaningful prevention of falls, such as balance and resistance exercise— Editorial accompanying the review
The Hearth Conversation Another angle on the story
Why did doctors start recommending these supplements so widely if the evidence was always this weak?
It made intuitive sense. Bones need calcium and vitamin D to stay strong. The logic was sound. Early studies suggested benefit, and guidelines built on that. But as more rigorous trials accumulated, the picture didn't hold up. By then, the recommendation had momentum—it was in guidelines, in practice, in people's medicine cabinets.
So this review is saying stop taking them entirely?
Not quite. The researchers are saying don't give them routinely to most older people expecting fracture prevention. For people with specific bone diseases or on osteoporosis drugs, the picture might be different. But for the general older population? The evidence doesn't support it.
What about people who already take them? Do they need to stop?
That's a conversation between them and their doctor. The review doesn't say the supplements are harmful. It says they don't prevent fractures the way we thought. Some people might have other reasons to take them—dietary deficiency, for instance. But the fracture prevention argument, which has driven so many prescriptions, doesn't hold.
If not supplements, what actually works?
Exercise. Specifically balance training and resistance work. Programs that teach people to move safely, to strengthen muscles, to reduce fall risk through movement rather than pills. It's less convenient than a supplement, but the evidence shows it works.
Why hasn't that become the standard recommendation?
Exercise is harder to prescribe. It requires sustained effort from the patient. It's not something you can hand someone in a bottle. Supplements fit the medical model better—take this, it will help. But the evidence suggests we've been looking in the wrong direction.